Navigation Links
Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients
Date:9/23/2011

ropenia [low white blood cell count] and thrombocytopenia [low platelet count]. The majority of patients were able to undergo multiple treatments in the PHP arm, as toxicity resolved, whereas the major toxicity in the control arm was liver failure and/or death on treatment from disease progression," he will say.

"This is the first treatment to show a clinical benefit in patients with liver metastases from ocular melanoma. Most patients retain 80% or more of their daily functional status, and return to full performance once therapy is completed. If subsequent recurrence is noted in the liver, retreatment is possible and effective. At this point, it appears that there are groups of patients surviving substantially longer than those control arm of the study, with good quality of liver and preservation of liver function."

PHP potentially could be used for other cancers that have spread to the liver. "We have demonstrated efficacy in a phase II setting for patients with metastatic neuroendocrine tumours [2], so the application of this technology is likely to expand to other tumour types," says Prof Pingpank. "In addition, we have previously demonstrated efficacy of high dose regional melphalan for patients with metastatic colorectal cancer, albeit through a different circuit."

The device that delivers and filters the melphalan has been approved in Europe for use in all malignant liver tumours, while approval is pending in the USA for melanoma only.

Prof Pingpank will conclude: "Certainly, with 50 percent of melanoma patients with metastatic liver disease dying of liver failure, we see this as a frontline therapy for patients with this disease. There is always controversy surrounding the application of regional therapy to patients with metastatic disease, especially when there is a high risk for metastases elsewhere in the body. However, at present, the dearth of options for patients with metastatic melanoma renders this a moot point,
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
2. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
3. Scientists identify microRNA as possible cause of chemotherapy resistance
4. Study evaluates costs and benefits of new chemotherapy drugs
5. Researchers find new chemotherapy combination shows promise in endometrial cancer
6. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
7. Recommended Dental Care for Chemotherapy Patients -- Advice from Steven McConnell, DDS
8. Pregnant women can receive breast cancer chemotherapy without endangering health of their babies
9. Making Your Way Through the Fog of Chemotherapy
10. Interruption of Menstrual Cycle by Chemotherapy Associated with Improved Survival in Early Breast Cancer
11. Ancient Chinese herbal recipe eases side effects of chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... William Mattar ... William Mattar, Esq. believes this does not stop at any certain demographic or segment ... its newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , The closed captioning ...
(Date:9/3/2015)... ... 03, 2015 , ... Topical BioMedics, Inc., hosted Amsterdam resident ... six-month, 10,000 mile journey from Santiago, Chile to Times Square and then Rhinebeck, ... Las Americas” project—Max crossed six countries in 168 days on his 39-year-old Moto ...
(Date:9/3/2015)... ... September 03, 2015 , ... Silverado next week lays ... Columbine Drive in Bellingham, Washington. Silverado Bellingham, a 41,000 square foot, single-story community, ... serve up to 80 people living with Alzheimer’s, dementia and other memory-impairing conditions. ...
(Date:9/3/2015)... ... September 03, 2015 , ... RealtyShares , the online ... institutional investors to real estate investment opportunities nationwide, today announced that it is ... investors and sponsoring real estate companies. , These products typically involve ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private companies ... "only a tiny fraction of the nation's companies have demonstrated such remarkably consistent ...
Breaking Medicine News(10 mins):Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2
... and Caitlin Mason from Queens University, Canada has reported in ... national surveys which reported the obesity// and overweight in Canadian ... between 1985 to 2003. The study showed an increasing trend ... a shift in BMI index from Class II to Class ...
... like that of viral flu are spreading across Delhi with ... a minimum of 0.2 degrees Celsius (7 degrees below normal) ... reached 11.6 degrees //(five degree above normal) on 17 January ... the weather change. ,‘There is a sudden ...
... approved the drug for use to treat the cancer multiple ... the Department of Health and Ageing. It is available through ... is to go to the PBS," as said by the ... the drug was originally used in Australia in the late ...
... died in Singapore a few days after the operation, and ... is reported to have suffered from a heart attack while ... transplant surgeon K.C. Tan. ,The recipient, a ... enough to go home. Tan said the donor was put ...
... of Science throws light on cells that could prevent ... in the February issue of Nature Neuroscience. ... led the study, //which might have important implication in ... The researchers say that immune cells play a key ...
... 39-year-old Mogjan Azari, a dentist who was jailed for one ... and is banned from practicisig. Azari allowed her boyfriend Omid ... devastating consequences. ,Mazaheri practiced on Azari's patients without ... days. On one occasion he broke a syringe in a ...
Cached Medicine News:Health News:Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function 2
(Date:9/3/2015)... , Sept. 3, 2015 Research and Markets ... "Radiology Information Systems Market by Type, Deployment Mode, ... Forecast to 2019" report to their offering. ... estimated at $501.1 Million 2014, and is projected to ... 7.6% from 2014 to 2019. The ...
(Date:9/3/2015)... -- The findings of a year-long investigation conducted by NBC ... handling of its Recovery IVC filter product ... part one of the series revealed that ... fatalities, have been associated with the Recovery device. NBC ... Bard in 2004 which linked the Recovery IVC filter ...
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... announced the addition of the "Investigation Report on ... As air pollution worsens, the incidence of ... size of relevant drugs. Bromhexine, a semisynthetic derivative of ... of chronic bronchitis and asthma associated with viscid or ...
Breaking Medicine Technology:Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3China Bromhexine Market Report 2015-2019 2
... Anpath Group, Inc.,(OTC Bulletin Board: ANPG), ... (ESI) announced the selection of its,disinfectant, EnviroTru(TM) ... Authority (Metro). EnviroTru(TM) is a multi-purpose ... and also meets EPA requirements for,Toxicity Category ...
... Presented at Anti-Angiogenesis Conference Shows R84, the Selective Human ... Affitech, Is Equivalent to Avastin in Inhibiting Growth of Established ... Tumors in a Preclinical Breast Cancer Model -- ... a Potential Clinical Candidate --, BOSTON and TUSTIN, Calif., ...
Cached Medicine Technology:Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 2Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 3New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 2New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 3New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 4New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 5
Farabeuf periosteal elevators....
OHL periosteal elevator, 19 cm, 7-1/2"....
Steinhauser periosteal elevator....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Medicine Products: